- Alzheimer disease
- Charcot-Marie-Tooth disease
- Epilepsy
- Forearm pain
- Gait abnormality
- Guillain-Barre syndrome
- Headache
- Memory disorder
- Mild cognitive impairment
- Movement disorder
- Multiple sclerosis
- Myasthenia gravis
- Nerve pain
- Neurological disorder
- Peripheral neuropathy
- Primary progressive aphasia (PPA)
- Stroke
- Transient ischemic attack
- Traumatic brain injury
David R. Lynch, MD, PhD
Neurology
Independent provider
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
About me
- Professor of Neurology
- Professor of Neurology in Pediatrics
My education and training
- Medical School: Johns Hopkins University School of Medicine
- Residency: University of Pennsylvania Health System
- Fellowship: University of Pennsylvania Health System
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
- Devoted Health Choice Giveback Pennsylvania (PPO)
- Devoted Health Choice Pennsylvania (PPO)
- Devoted Health Choice Plus Pennsylvania (PPO)
- Devoted Health Core Pennsylvania (HMO)
- Devoted Health Dual Plus Pennsylvania (HMO D-SNP)
- Devoted Health Giveback Pennsylvania (HMO)
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Lynch is an independent physician who is not employed by Penn Medicine.
Qualifications and experience
- Neurology, 1993
- American Academy of Neurology, National
- American Neurological Association, International
- Australian Medical Research Council, International
- Cooperative Ataxia Group (CAG), National
- French Government Scientific Review, International
- Friedreich Ataxia Research Alliance, National
- Government, Czech Republic, International
- MDA, National
- National Ataxia Foundation, National
- NIH, National
- NIH RAID Program, National
- NINDS Committee on Common Data Elements, International
- Society for Neuroscience, National
Treatments and conditions
Research
Publications
Morgan C Devore 1, Christina Lam 2, Emily Xiao 2, Jeremy Devore 2, Kassandra R C McCain 2, Graham Wiley 3, Courtney C Park 4, David R Lynch 4, Sanjay I Bidichandani FXN protomutations are the source of pathogenic expanded GAA alleles in Friedreich ataxia and explain its unequal population distribution , Hum Mol Genet , 35(11): 2026 ,ddag046.
Elizabeth Mercado-Ayon; Jennifer Coulman; Jia-Ying Lee; Eunjoo Lancaster; Elliot Goga; Mohammad Asad; Eric Witze Impaired Glur2 Palmitoylation in Cerebellar Purkinje Cells of a Friedreich Ataxia Mouse Model , Exp Neurol, 406(115955.): 2026
Lynch DR, Keita M, Gunther K, Park C, Schadt K, Mercer-Rosa L, Lin KY. Serial assessment of echocardiographic measures in Friedreich ataxia. , Am Heart J Plus, 70(100869.): 2026
Gitman, a., Bhandari, N., Castellano, M, Schadt, K., Cancio, M, Lynch, D. R. Stem cell transplantation in Friedreich ataxia: Cure for Leukemia but no effect on neurological progression , Annals Clinical and Translational Neurol, 13(8): 2026,1733-1735
Ali SAH, Early J, Farmer JM, Gelbard S, Corben L, Rance G, Lynch DR. Listening in Spatialized Noise-Sentences (LiSN-S) as a Measure of Auditory Function in Friedreich Ataxia. , Cerebellum, 25(3): 2026,60
Satoshi Miyashita, Anthony Zaki, Kaitlin Schlabach, Gabriel Kim, Juliane K. Vierecke, David Lynch, Carmela Tan, Eileen Hsich, Paulino Alvarez Advanced Heart Failure in Friedreich's Ataxia: A Story of Challenges, Opportunities, and Hope , JACC: Case Reports, 31(17): 2026,107391.
Gaetz W, Saleh MG, Birnbaum C, Bloy L, Roberts TPL, Lynch DR. Myo-inositol elevation as an in vivo marker of reactive gliosis in pediatric Friedreich ataxia: evidence from HERMES-edited MR spectroscopy , Neuroimage: Clinical, 50:: 2026,103983.
Devore, M, Lam, C, Wiley, C, Park, CC, Lynch, DR, Bidichandani, S Unrecognized high prevalence of expanded composite repeats in Friedreich ataxia , Hum Mol Gen, 35(3): 2026,:ddaf190.
Lazaropolous, MP, Devore, M, Bidichandani, SJ, LynchD.R. Compound Heterozygote Friedreich Ataxia Patients With Covert Proximal FXN Gene Deletion , Annals of Clinical and Translational Neurology: 2026
Rummey C, Thomas-Black G, Garcia-Moreno H, Lynch DR, Abeti R, Arisoy H, Heslegrave A, Zetterberg H, Giunti P; European Friedreich's Ataxia Consortium for Translational Studies (EFACTS). Increase of Plasma Biomarkers in Friedreich's Ataxia: Potential Insights into Disease Pathology , Movement disorders, 409: 2025,1863-1873.